Peregrine Capital Management’s Privia Health PRVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.51M	Sell	316,718 -13,594	-4%	-$306K	0.24%	125
2025 Q4	$7.83M	Sell	330,312 -4,247	-1%	-$103K	0.24%	119
2025 Q3	$8.33M	Sell	334,559 -8,733	-3%	-$188K	0.25%	108
2025 Q2	$7.9M	Buy	343,292 +13,162	+4%	+$305K	0.24%	122
2025 Q1	$7.41M	Buy	330,130 +9,362	+3%	+$218K	0.25%	116
2024 Q4	$6.27M	Buy	320,768 +5,759	+2%	+$114K	0.19%	166
2024 Q3	$5.74M	Buy	315,009 +819	+0.3%	+$15.6K	0.17%	191
2024 Q2	$5.46M	Buy	314,190 +32,311	+11%	+$572K	0.16%	218
2024 Q1	$5.52M	Buy	281,879 +58,640	+26%	+$1.24M	0.16%	222
2023 Q4	$5.14M	Sell	223,239 -66,975	-23%	-$1.5M	0.15%	226
2023 Q3	$6.67M	Buy	290,214 +35,948	+14%	+$914K	0.2%	205
2023 Q2	$6.64M	Buy	254,266 +68	+0%	+$1.8K	0.18%	224
2023 Q1	$7.02M	Sell	254,198 -20,269	-7%	-$535K	0.2%	215
2022 Q4	$6.23M	Buy	274,467 +63,942	+30%	+$1.78M	0.2%	221
2022 Q3	$7.17M	Sell	210,525 -63,191	-23%	-$2.34M	0.23%	201
2022 Q2	$7.97M	Sell	273,716 -30,839	-10%	-$784K	0.24%	186
2022 Q1	$8.14M	Sell	304,555 -22,457	-7%	-$530K	0.19%	213
2021 Q4	$8.46M	Buy	327,012 +9,416	+3%	+$235K	0.17%	224
2021 Q3	$7.48M	Buy	317,596 +11,392	+4%	+$398K	0.16%	233
2021 Q2	$13.6M	Buy	+306,204	New	+$11.3M	0.24%	190